Item 5. Other Information
Item 5. Other Information
Rule 10b5-1 Trading Plans
None of the Company’s directors or officers
adopted , modified , or terminated a Rule 10b5-1 trading arrangement or a non-Rule 10b5-1 trading arrangement during the Company’s
fiscal quarter ended March 31, 2026.
Item 6. Exhibits
Exhibit
Number
Description
3.1
Fourth Amended and Restated Certificate of Incorporation of the Company, as amended [Restated for SEC filing purposes only] (incorporated by reference to Exhibit 3.1 to the Company’s Annual Report on Form 10-K filed on March 31, 2026)
3.2
Amended and Restated Bylaws of the Company (incorporated by reference to Exhibit 3.4 to the Company’s Registration Statement on Form S-1 (File No. 333-214724), as amended, originally filed on November 21, 2016)
31.1
Certification
of Periodic Report by Principal Executive Officer pursuant to Rule 13a-14(a)/15d-14a and pursuant to Section 302 of the Sarbanes-Oxley
Act of 2002 (filed herewith)
31.2
Certification
of Periodic Report by Principal Financial Officer pursuant to Rule 13a-14(a)/15d-14a and pursuant to Section 302 of the
Sarbanes-Oxley Act of 2002 (filed herewith)
32.1
Certification
of Periodic Report by Principal Executive Officer and Principal Financial Officer pursuant to U.S.C. Section 1350, as adopted pursuant
to Section 906 of the Sarbanes-Oxley Act of 2002 (furnished herewith)
101.INS
XBRL
Instance Document (filed herewith)
101.SCH
XBRL
Taxonomy Schema (filed herewith)
101.CAL
XBRL
Taxonomy Extension Calculation Linkbase (filed herewith)
101.DEF
XBRL
Taxonomy Extension Definition Linkbase (filed herewith)
101.LAB
XBRL
Taxonomy Extension Label Linkbase (filed herewith)
101.PRE
XBRL
Taxonomy Extension Presentation Linkbase (filed herewith)
104
Cover
Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)
25
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
ENDRA LIFE SCIENCES INC.
Date: May 15, 2026
By:
/s/ Alexander Tokman
Alexander Tokman
Chief Executive Officer and Chairman
(Principal Executive Officer)
ENDRA LIFE SCIENCES INC.
Date: May 15, 2026
By:
/s/ Richard Jacroux
Richard Jacroux
Chief Financial Officer
(Principal Financial and Accounting Officer)
26
Text extracted from the filing as submitted to EDGAR. Formatting, tables and exhibits are simplified for reading; the original document is authoritative for anything you rely on.